The science is evolving rapidly, with multiple high-quality studies published in leading peer-reviewed journals consistently suggesting that GLP-1 therapy may offer meaningful protective effects against a range of obesity-related malignancies through mechanisms that operate both dependently and independently of weight loss
Ethics declarations Competing interests All authors are employees of Heptares Therapeutics Ltd and are shareholders in Sosei Group Corporation
The hormone GLP-1 is also a neurotransmitter and communicates directly with an area in the brain that regulates appetite, called the hypothalamus
They point to effects beyond appetite suppression, from reduced inflammation to possible direct signalling on tumour cells. F&B takeaway: It almost goes without saying that GLP-1s for cancer prevention or treatment would dramatically accelerate their adoption, both in private use and in public health systems, shifting them firmly into the health space
21-0193A, the pharmacy was fined $5,000 and agreed it would not reopen or own any facility requiring a Kentucky pharmacy permit
To be eligible for either of these from Chemist4U, you must be 18 years or older and: be medically obese (have a BMI of over 30) or be overweight with weight-related issues (a BMI of over 27 and a condition like: high cholesterol, high blood pressure, or type 2 diabetes) Your consultation will be reviewed by one of our GPHC-registered prescribing clinicians, and if you are eligible, you may be able to receive them from our online service.
